Fidelity Advisor Biotechnology Fund - Class A (FBTAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
27.27
+0.01 (0.04%)
Mar 7, 2025, 8:02 PM EST
-10.56%
Fund Assets 1.50B
Expense Ratio 1.01%
Min. Investment $0.00
Turnover n/a
Dividend (ttm) 1.63
Dividend Yield 5.69%
Dividend Growth 418.10%
Payout Frequency Annual
Ex-Dividend Date Dec 26, 2024
Previous Close 27.26
YTD Return 0.22%
1-Year Return -10.56%
5-Year Return 36.49%
52-Week Low 25.97
52-Week High 34.77
Beta (5Y) 0.53
Holdings 97
Inception Date Dec 27, 2000

About FBTAX

The investment seeks capital appreciation. The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

Fund Family Fidelity
Category Health
Performance Rating Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol FBTAX
Share Class Class A
Index S&P 500 TR

Performance

FBTAX had a total return of -10.56% in the past year. Since the fund's inception, the average annual return has been 6.72%, including dividends.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
FIJYX Class Z 0.61%
FBTIX Class I 0.74%
FBTTX Class M 1.29%
FBTCX Class C 1.76%

Top 10 Holdings

57.80% of assets
Name Symbol Weight
AbbVie Inc. ABBV 21.42%
Regeneron Pharmaceuticals, Inc. REGN 6.23%
Amgen Inc. AMGN 5.86%
Alnylam Pharmaceuticals, Inc. ALNY 5.23%
Vertex Pharmaceuticals Incorporated VRTX 4.62%
argenx SE ARGX 4.52%
Ascendis Pharma A/S ASND 3.85%
Vaxcyte, Inc. PCVX 2.25%
Viridian Therapeutics, Inc. VRDN 1.93%
Nuvalent, Inc. NUVL 1.90%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 26, 2024 $1.632 Dec 27, 2024
Dec 21, 2023 $0.315 Dec 22, 2023
Dec 17, 2021 $5.364 Dec 20, 2021
Jul 9, 2021 $0.103 Jul 12, 2021
Dec 18, 2020 $2.840 Dec 21, 2020
Dec 20, 2019 $1.880 Dec 23, 2019
Full Dividend History